Economics of the Pharmaceutical Industry
From PHM Oz
Revision as of 23:51, 10 July 2007 by DavidLegge (Talk | contribs)
High profits justified in terms of generating funds for drug development but relatively low proportion of revenues going to research
Mal-distribution of research funds: more towards me-too drugs and less to Type III drugs investment in drug development
Research often funded by public purse (universities) but profits go to industry.
